Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) EPS (Basic) (2018 - 2025)

Dna X (SONM) has disclosed EPS (Basic) for 8 consecutive years, with -$18.23 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Basic) fell 3405.77% year-over-year to -$18.23, compared with a TTM value of $20.23 through Sep 2025, up 869.2%, and an annual FY2024 reading of -$7.13, down 35550.0% over the prior year.
  • EPS (Basic) was -$18.23 for Q3 2025 at Dna X, down from -$0.99 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $39.37 in Q4 2024 and bottomed at -$18.23 in Q3 2025.
  • Average EPS (Basic) over 5 years is $0.7, with a median of -$0.36 recorded in 2021.
  • Peak annual rise in EPS (Basic) hit 78840.0% in 2024, while the deepest fall reached 6600.0% in 2024.
  • Year by year, EPS (Basic) stood at -$0.36 in 2021, then soared by 141.67% to $0.15 in 2022, then crashed by 133.33% to -$0.05 in 2023, then skyrocketed by 78840.0% to $39.37 in 2024, then crashed by 146.3% to -$18.23 in 2025.
  • Business Quant data shows EPS (Basic) for SONM at -$18.23 in Q3 2025, -$0.99 in Q2 2025, and $0.08 in Q1 2025.